Patents by Inventor Benjamin L. Ebert

Benjamin L. Ebert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Clonal Hematopoiesis and Risk of Chronic Liver Disease
    Publication number: 20220275079
    Abstract: This application provides for methods of treatment for liver disease, especially in subjects with a DNMT3A, TET2, JAK2, and/or ASXL1. The application also provides for methods of diagnosing liver disease, as well as kits for use in the claimed methods.
    Type: Application
    Filed: November 17, 2021
    Publication date: September 1, 2022
    Inventors: Connor Emdin, Waihay Wong, Benjamin L. Ebert, Pradeep Natarajan
  • PEPTIDE TAGS FOR LIGAND INDUCED DEGRADATION OF FUSION PROTEINS
    Publication number: 20220098251
    Abstract: Described herein are compositions and methods for modulating protein abundance in a target-specific manner via degron tags.
    Type: Application
    Filed: December 18, 2019
    Publication date: March 31, 2022
    Applicants: DANA-FARBER CANCER INSTITUTE, INC., THE GENERAL HOSPITAL CORPORATION
    Inventors: Eric Fischer, Benjamin L. Ebert, Max Jan, Radoslaw Nowak
  • Method of identifying and treating a person having a predisposition to or afflicted with a cardiometabolic disease
    Patent number: 11168369
    Abstract: The invention relates to method for identifying and selecting a subject with increased risk of developing a cardiometabolic disease and optionally, providing a personalized medicine method, which may involve sequencing at least part of a genome of one or more cells in a blood sample of the subject and identifying from said sequencing one or more mutations in one or more somatic mutations.
    Type: Grant
    Filed: November 25, 2015
    Date of Patent: November 9, 2021
    Assignees: The Brigham and Women's Hospital, Inc., The General Hospital Corporation
    Inventors: Benjamin L. Ebert, Siddhartha Jaiswal, Sekar Kathiresan
  • COMPOUNDS AND METHODS FOR TARGETING LEUKEMIC STEM CELLS
    Publication number: 20130338092
    Abstract: This invention relates to high-throughput, semi-automated methods for identifying compounds that are effective in targeting leukemia stem cells, as well as compounds identified by those methods and uses thereof for treating leukemia.
    Type: Application
    Filed: August 16, 2013
    Publication date: December 19, 2013
    Inventors: Kimberly Hartwell, Malcolm A.S. Moore, David T. Scadden, Stuart L. Schreiber, Todd R. Golub, Benito Munoz, Benjamin L. Ebert, Andrew M. Stern, Peter G. Miller, D. Gary Gilliland, Anne Van Dyk Carpenter, David J. Logan, Joseph Negri, Nicola Tolliday, Alykhan Shamji, Siddhartha Mukherjee, Alison Stewart